Page last updated: 2024-11-08

1-methyl-2-(3-pyridyl)azetidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-methyl-2-(3-pyridyl)azetidine: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID163827
CHEMBL ID321099
SCHEMBL ID156115
MeSH IDM0150717

Synonyms (12)

Synonym
1-mpatd
CHEMBL321099
3-(1-methylazetidin-2-yl)pyridine
110716-86-4
1-methyl-2-(3-pyridyl)azetidine
pyridine, 3-(1-methyl-2-azetidinyl)-, (+-)-
SCHEMBL156115
AQTJADRDDFZHKK-UHFFFAOYSA-N
n-methyl-2-(3-pyridyl)azetidine
62247-28-3
methyl-2-(3-pyridyl) -azetidine
DTXSID10911835
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID146635Binding affinity at heteropentameric Nicotinic acetylcholine receptor alpha4-beta2 subtype using [3H]bungarotoxin as radioligand1999Journal of medicinal chemistry, Aug-12, Volume: 42, Issue:16
Molecular recognition in nicotinic acetylcholine receptors: the importance of pi-cation interactions.
AID147084Binding affinity at homopentameric Nicotinic acetylcholine receptor alpha-7 subtype using [3H]S-(-)-nicotine as radioligand; Not determined1999Journal of medicinal chemistry, Aug-12, Volume: 42, Issue:16
Molecular recognition in nicotinic acetylcholine receptors: the importance of pi-cation interactions.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (20.00)18.7374
1990's4 (80.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 13.09

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index13.09 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.88 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (13.09)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (20.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]